Desktop Metal, Inc.
New York Stock ExchangeRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- Desktop Metal, Inc. (NYSE: DM) designs, manufactures, and sells additive manufacturing systems specializing in binder jetting and digital light processing technologies for metal, polymer, ceramic, and composite 3D printing; its core products include the Shop System for office-friendly metal part production, the P-Series (P1 and P50) for high-speed mass production of fully dense metal parts via single-pass binder jetting, the X-Series platform for binder jet 3D printing of specialty metals and ceramics, Production System for batch production of customer-ready metal parts featuring patented Triple ACT for surface quality, and materials such as binder jetting powders, photopolymer resins including DuraChain 2-in-1 pot resins and Flexcera, BMD materials, bioprinting materials, and upcycled options like wood. Founded in 2015 and headquartered in Burlington, Massachusetts, the company operates engineering facilities across the United States (California, Michigan, New Jersey, Ohio, Pennsylvania, Texas), as well as Germany, Italy, Belgium, and Japan, with a distribution network spanning over 65 countries and more than 200 partners serving industries including automotive, aerospace, healthcare, consumer products, heavy industry, electronics, industrial automation, medical technology, research and development, academia, and government organizations primarily in the Americas, Europe, the Middle East, Africa, and Asia-Pacific. In April 2025, Nano Dimension Ltd. completed its acquisition of Desktop Metal for $179.3 million, integrating it as a subsidiary to form a complementary portfolio of advanced manufacturing solutions with combined annual revenue exceeding $200 million for 2024, expanded customer base among Fortune 500 companies, and a refreshed leadership team focused on cost synergies, operational efficiencies, resource realignment to high-potential product lines, and sustainable business model transformation; the company additionally advances a pending merger with Markforged to further bolster its additive manufacturing capabilities.
FDA Grants Breakthrough Therapy Designation for Calderasib (MK-1084), an Investigational KRAS G12C Inhibitor, for Certain Patients with Newly Diagnosed Metastatic KRAS G12C-Mutant Non-Small Cell Lung
Imagine Health Achieves Teaching Facility Status Through University of Calgary Faculty Partnership
Datametrex Receives $6M Purchase Order for Data Centre from Fortune 500 Conglomerate
Datametrex Subsidiary PayMetrex Highlights Strategic Relevance of Patent Portfolio to Rapidly Expanding SoftPOS Market
Datametrex Integrates AI to Healthcare To Enhance Efficiencies
Paymetrex Engages Pelent AI to Accelerate Patent Licensing Program
Datametrex Receives $1M Order from Fortune 500 Client
Datametrex Received $500,000 Purchase Order For Data Centre Solutions
Paymetrex Secures First U.S. License Payment
Datametrex Expands Business In Data Centres
Paymetrex Launches Patent Licensing Program to Monetize Mobile Payments IP Portfolio
Datametrex Announces Participation in AlphaNorth Capital Event
Paymetrex and AnywhereCommerce Solidify Relationship
DataMetrex Announces Closing of Yuzu Payment Processing Solution Acquisition
Datametrex Secures Approximately $650,000 Purchase Orders
Imagine Health Calgary and Edmonton Welcome New Physicians and Accept New Patients
DataMetrex Announces New Edmonton South Location For Imagine Health
DataMetrex Announces New Calgary Location for Imagine Health
Datametrex Announces Closing of Financings
Datametrex Announces Closing Date for Financings